WPRIM Management System> DCMS> Asian Journal of Andrology> 2018> 20> 3

Volume: 20 Issue: 3

1. The path forward in prostate cancer therapeutics Page:213—214
2. Bone-targeted therapies to reduce skeletal morbidity in prostate cancer Page:215—220
3. Role of chemotherapy in prostate cancer Page:221—229
4. Utility of cell-free nucleic acid and circulating tumor cell analyses in prostate cancer Page:230—237
5. The role of peroxisome proliferator-activated receptor gamma in prostate cancer Page:238—243
6. Vitamin D in prostate cancer Page:244—252
7. Perspectives on the clinical development of immunotherapy in prostate cancer Page:253—259
8. Altered PIWI-LIKE 1 and PIWI-LIKE 2 mRNA expression in ejaculated spermatozoa of men with impaired sperm characteristics Page:260—264
9. Histological subtype is a significant predictor for inguinal lymph node metastasis in patients with penile squamous cell carcinoma Page:265—269
10. Intermittent, low-dose, antiandrogen monotherapy as an alternative therapeutic option for patients with positive surgical margins after radical prostatectomy Page:270—275
11. Androgen receptor deficiency in monocytes/macrophages does not alter adiposity or glucose homeostasis in male mice Page:276—283
12. Transcription and regulation of hepatitis B virus genes in host sperm cells Page:284—289
13. Proton-pump inhibitor use does not affect semen quality in subfertile men Page:290—293
14. The transcription factor ZEB1 promotes an aggressive phenotype in prostate cancer cell lines Page:294—299
15. ASIC1a contributes to the symptom of pain in a rat model of chronic prostatitis Page:300—305
16. MRI feature analysis of uncommon prostatic malignant tumors. Page:313—315
17. The role of peroxisome proliferator-activated receptor gamma in prostate cancer. Page:238—243
18. Redo surgery for failed hypospadias treatment using a novel single-stage repair. Page:311—312
19. Zinner's syndrome: clinical features and imaging diagnosis. Page:316—317
20. A rare polypyrimidine tract mutation in the androgen receptor gene results in complete androgen insensitivity syndrome. Page:308—310
21. Microdissection testicular extraction for a patient with transverse testicular ectopia and testicular fusion. Page:306—307
22. Proton-pump inhibitor use does not affect semen quality in subfertile men. Page:290—293
23. Role of chemotherapy in prostate cancer. Page:221—229
24. Transcription and regulation of hepatitis B virus genes in host sperm cells. Page:284—289
25. Androgen receptor deficiency in monocytes/macrophages does not alter adiposity or glucose homeostasis in male mice. Page:276—283
26. ASIC1a contributes to the symptom of pain in a rat model of chronic prostatitis. Page:300—305
27. The transcription factor ZEB1 promotes an aggressive phenotype in prostate cancer cell lines. Page:294—299
28. Intermittent, low-dose, antiandrogen monotherapy as an alternative therapeutic option for patients with positive surgical margins after radical prostatectomy. Page:270—275
29. Altered PIWI-LIKE 1 and PIWI-LIKE 2 mRNA expression in ejaculated spermatozoa of men with impaired sperm characteristics. Page:260—264
30. Histological subtype is a significant predictor for inguinal lymph node metastasis in patients with penile squamous cell carcinoma. Page:265—269
31. Commentary on "Altered PIWI-LIKE 1 and PIWI-LIKE 2 mRNA expression in ejaculated spermatozoa of men with impaired sperm characteristics". Page:318—318
32. The path forward in prostate cancer therapeutics. Page:213—214
33. Bone-targeted therapies to reduce skeletal morbidity in prostate cancer. Page:215—220
34. Utility of cell-free nucleic acid and circulating tumor cell analyses in prostate cancer. Page:230—237
35. Perspectives on the clinical development of immunotherapy in prostate cancer. Page:253—259
36. Vitamin D in prostate cancer. Page:244—252